Milbank LLP represented the financing sources of a senior secured credit facility in support of Kelso & Company’s investment in Vālenz® Health (“Valenz”).
Valenz simplifies the complexities of self-insurance for employers through a steadfast commitment to data transparency and decision enablement powered by its Healthcare Ecosystem Optimization Platform.
The Milbank team was led by New York-based Global Leveraged Finance partners Marcus Dougherty and Charles Stern, and included associates Gregory Arpino, Nick Morgan and Christine Qin.
